Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Engineered T Cell Receptors With Built-In ICOS Deliver Long-Lasting
1+ day, 5+ hour ago (120+ words) Adoptive T cell therapy has delivered striking remissions in some blood cancers, but its promise in solid tumors has been repeatedly undermined by a stubborn problem: the therapeutic cells do not last. Engineered T cells that flood a tumor and…...
Why Blocking One Immune Enzyme Fails: Cells Reroute Tryptophan Metabolism
1+ day, 18+ hour ago (743+ words) For more than a decade, the enzyme indoleamine 2,3-dioxygenase 1, better known as IDO1, has been one of immunology’s most tempting drug targets....
NaNotics Study Demonstrates New Nanotechnology Approach to Cancer Immunotherapy - AOL
5+ day, 7+ hour ago (186+ words) New peer-reviewed research from Mayo Clinic and NaNotics LLC demonstrates a novel approach to cancer immunotherapy: engineered adsorptive nanoparticles called NaNots® selectively deplete a soluble protein that tumors use to suppress immune response and enable tumor growth. NaNots lacking the…...
Vaccine Adjuvant Injected Straight Into a Dog’s Tumor Sparks a Hidden
3+ day, 4+ hour ago (668+ words) In a development that could reshape how veterinarians and oncologists think about treating solid tumors, researchers have reported that injecting an experimental immune-stimulating compound directly into a canine soft tissue sarcoma triggered a striking influx of immune cells into what…...
Multiplexed Saliva-based Immunodiagnostics for Assessing Anti-flavivirus Immunity
3+ day, 18+ hour ago (86+ words) An easy-to-use method for rapidly, accurately, and non-invasively assessing flavivirus immunity by measuring various antibody classes present in saliva. image: Read more about the new world-class SUNY discoveries that are available for licensing at SUNY TechConnect. The Research Foundation offers…...
UCLA scientists turn cord blood into powerful cancer-fighting T cells
3+ day, 10+ hour ago (1233+ words) UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through two separate detection systems. In mice, a single dose controlled cancer and extended survival while avoiding a dangerous complication associated with donor-derived…...
GC Biopharma wins phase 2 nod for COVID-19 mRNA shot, targets Korea production by 2028
3+ day, 6+ hour ago (17+ words) CHOSUNBIZ Chosunbiz...
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
3+ day, 16+ hour ago (184+ words) New York, USA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight The CAR T-cell therapy for NHL clinical trial analysis report delivers important insights into ongoing research of 75+ pipeline CAR…...
VVMF, Australia's First Viral Vector CDMO Receives TGA Manufacturing Licence
3+ day, 20+ hour ago (366+ words) wahanariau.com VVMF, Australia's First Viral Vector CDMO Receives TGA Manufacturing Licence Regulatory milestone strengthens Australia’s sovereign advanced therapeutics manufacturing capability SYDNEY, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first viral vector Contract Development and Manufacturing…...
Why does the immune system sometimes help tumors grow?
3+ day, 15+ hour ago (540+ words) Salk Institute researchers define how chronic interferon exposure prompts a switch from anti-tumor activity to immunosuppression in mice, revealing a key target to sustain anti-tumor immune responses and combat immunotherapy-resistant cancer LA JOLLA—Cancer biology and, in turn, cancer treatment…...